EIGR

Eiger BioPharmaceuticals, Inc.
EIGR

Overview Fund Activity
Delisted

EIGR was delisted on the 10th of April, 2024.

Back to rankings

51 hedge funds and large institutions have $70.4M invested in Eiger BioPharmaceuticals, Inc. in 2016 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 10 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
51
Holders Change
+4
Holders Change %
+8.51%
% of All Funds
1.28%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
9
Increased
16
Reduced
10
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
MIM
Monashee Investment Management
Massachusetts
$367K
2
PA
Perceptive Advisors
New York
$1.84M
3
BFA
BlackRock Fund Advisors
California
$1.53M
4
Deutsche Bank
Deutsche Bank
Germany
$474K
5
SFM
Sphera Funds Management
Israel
$4.49M

Top Sellers

1
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University
California
$0
2
DCM
DAFNA Capital Management
California
$468K
3
Wellington Management Group
Wellington Management Group
Massachusetts
$3.23M
4
AIM
Acrospire Investment Management
Illinois
$0
5
Vanguard Group
Vanguard Group
Pennsylvania
$1.7M
Name Holding Trade Value Shares
Change 		Shares
Change %
BOTOTLSJU
51
Board of Trustees of The Leland Stanford Junior University
California
– -$1.46M -3,635 Closed
AIM
52
Acrospire Investment Management
Illinois
– -$67K -168 Closed
TRCT
53
Tower Research Capital (TRC)
New York
– -$2K -5 Closed
1 2
3